Monday , December 11 2017
Home / Resources / Products / FDA Okays First Direct Renin Inhibitor for Hypertension

FDA Okays First Direct Renin Inhibitor for Hypertension

FDA Okays First Direct Renin Inhibitor for Hypertension
The FDA has approved aliskiren (Tektuma), the first oral direct renin inhibitor for treatment of hypertension. The drug is the first in a new class of agents known as oral renin inhibitors and is approved for the treatment of high blood pressure as monotherapy or in combination with other antihypertensive medications.  See this week’s Item#12